NEW YORK, Dec. 4, 2014 /PRNewswire/ -- Securities lawyers
at Dunnam & Dunnam are investigating the board of Avanir
Pharmaceuticals Inc. (NASDAQ: AVNR) in connection with a buyout for
only $17.00 per share. Concerned AVNR
investors are encouraged to contact attorney Hamilton Lindley by
clicking here.
The investigation focuses upon the shareholder value of the
transaction. This offer appears to deeply discount the chances of
success in Alzheimer's agitation, and Jefferies has valued the
stock at $26.00 to $31.00 in the
event of an acquisition. The firm's potential shareholder lawsuit
will seek to obtain the highest price reasonably available and that
all important information about the deal is disclosed.
Dunnam & Dunnam has significant experience representing
shareholders in securities lawsuits nationwide. AVNR stockholders –
or anyone with knowledge about this situation – should contact
lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions,
toll free at (844) 702-2990 or visit
http://www.dunnamlaw.com/AVNR.
Hamilton Lindley
Dunnam Dunnam Harmon West Lindley
& Ryan LLP
4125 W. Waco Drive
Waco, TX 76710
(844) 702-2990 Toll Free
(254) 753-6437 Telephone
(254) 753-7434 Facsimile
hlindley@dunnamlaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-inc-stockholders-encouraged-to-contact-securities-law-firm-about-takeover-300004946.html
SOURCE Dunnam & Dunnam